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ABSTRACT: 11 
The flavonoid components of New Zealand mānuka (Leptospermum scoparium) honey have been 12 
quantified in a series of 31 honeys of varying non-peroxide antibacterial activity to clarify 13 
discrepancies between previous studies reported in the literature.  Total flavonoid content was 14 
1.16 mg/100 g honey.  The principal flavonoids present were pinobanksin, pinocembrin, luteolin 15 
and chrysin and together these represented 61% of the total flavonoid content.   1, 2-formyl-5-(2-16 
methoxyphenyl)-pyrrole , which was weakly correlated with the non-peroxide antibacterial activity, 17 
was isolated from the flavonoid fraction and separately synthesised.  1 did not display inhibitory 18 
activity against S. aureus in vitro and thus the origin of the correlation, which is still unknown, is not 19 
a direct contribution.  20 
21 
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INTRODUCTION: 22 
New Zealand mānuka (Leptospermum scoparium) honey is noted for its non-peroxide antibacterial 23 
activity (Allen, Molan & Reid, 1991). This activity has been attributed principally to the presence of 24 
methylglyoxal (Adams et al., 2008, Mavric, Wittman, Barth & Henle, 2008), which originates from 25 
dihydroxyacetone in the nectar of the flower (Adams et al., 2009), the reasons why some 26 
individuals of this species produce high levels of  dihydroxyacetone are unknown.  Because of its 27 
non-peroxide antibacterial activity, New Zealand mānuka honey commands a premium price world-28 
wide and is thus subject to fraud and substitution;  to establish authenticity, markers of floral origin 29 
are urgently needed.  Flavonoid profiles have been used to determine the floral origin of honeys 30 
(Tomas-Barberan, Ferreres, Garcia-Viguera & Tomas-Lorente, 1992, Tomas-Barberan, Ferreres, 31 
Garcia-Viguera & Tomas-Lorente, 1993, Anklam, 1998); flavonoids thus represent a possible 32 
biomarker for mānuka honey.  Flavonoids are known for their antibacterial and other bioactivities 33 
(Cushnie & Lamb, 2005, Havsteen, 2002, D’Arcy, 2005) and there exists a possibility that one or 34 
more components of the flavonoid fraction of mānuka honey contribute directly or indirectly (by 35 
involvement in the biosynthetic pathway generating high levels of dihydroxyacetone) to the non-36 
peroxide antibacterial activity of the honey.  Weston, Brocklebank and Lu (2000) found the 37 
principal flavonoids in mānuka honey to be pinobanksin  with 4.3, 6.3, 5.0 g/100g honey  38 
respectively for  high (10 samples), low (3 samples) and zero (6 samples) antibacterial activity 39 
respectively , pinocembrin with 5.1, 7.3, 4.5.0 g/100g  honey for  high, low and zero antibacterial 40 
activity respectively, chrysin with 2.2, 2.7, 2.2 g/100g honey for  high, low and zero antibacterial 41 
activity respectively and galangin with 2.2, 3.4, 1.9 g/100g  honey for  high, low and zero 42 
antibacterial activity respectively. This is in contrast to the work of Yao, Datta, Tomas-Barberan, 43 
Ferreres, Martos and Singanusong (2003), who found the principal flavonoids in two samples of 44 
mānuka honey to be quercetin (430 g/100g  honey), isorhamnetin (400 g/100g  honey), an 45 
unknown flavonoid (390 g/100g  honey), chrysin (380 g/100g  honey) and luteolin (380 g/100g  46 
honey) with a total flavonoid content of 3060 g/100g  honey. There is a very marked qualitative 47 
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and quantitative difference between these two sets of results and indeed Yao et al. (2003) 48 
recommended further analysis of New Zealand mānuka honeys using a large sample set and the 49 
HPLC detection methodology that they espoused, that is detection of flavonones at 290 nm and of 50 
flavones at 340 nm using diode array detection. 51 
Pyrroles in honey can arise from Maillard reactions or from the pyrolysis of amino acids when 52 
honey is heated (Jerković,  Mastelić, Marijanović, Klein & Jelić, 2007). 1H-Pyrrole has been found in 53 
Robinia pseudoacacia L., Castanea sativa L. and Salvia officinalis L (Jerković et al., 2007, Jerković,  54 
Mastelić & Marijanović , 2006).  1H-Pyrrole-2-carboxylic acid has been found in Paliurus spina-55 
christi (Jerković,  Tuberoso, Marijanović, Jelić & Kasum, 2009). 2-Acetylpyrrole has been found in 56 
abbamele, a honey-based Sardinian product (Jerković,  Kasum, Marijanović & Tuberoso, 2011) and 57 
1H-pyrrole-3,4-diacetic acid has been found in pine honey (Pinus brutia Ten) (Eraslan, Kanbur, Silici 58 
& Karabacak, 2010).  Phenyl substituted pyrroles are also found in natural products, pyrrolnitrin is a 59 
tryptophan-derived, antifungal antibiotic isolated from Pseudomonas pyrrocinia (van Pée & Ligon, 60 
2000). Both pentachloropseudilin and pentabromopseudilin, which are produced by an 61 
Actinoplanes sp. strain, are strongly active against Gram-positive bacteria. The latter is also known 62 
to inhibit a number of different enzyme systems and has high in vitro activity against leukemia and 63 
melanoma cell lines (van Pée & Ligon, 2000). 64 
This study aimed to investigate the flavonoid  profiles  of a large sample set of New Zealand 65 
mānuka honeys using the detection methods suggested by Yao et al. (2003) and to establish if 66 
there was any link between this profile and the afore-mentioned non-peroxide antibacterial activity, 67 
which is a feature of these honeys. During the course of this investigation an unidentified peak in 68 
the HPLC chromatogram of the flavonoid fraction was shown to be weakly correlated to 69 
antibacterial activity. The compound, 2-formyl-5-(2-methoxyphenyl)-pyrrole , 1, was subsequently 70 
isolated from the flavonoid fraction and fully characterised.  71 
  72 
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MATERIALS AND METHODS 73 
Materials:  Thirty one  mānuka honey samples with non-peroxide antibacterial activities ranging 74 
from very low to 27.3 UMF™, were kindly supplied by Comvita New Zealand Ltd., Te Puke, New 75 
Zealand. A bulk sample of active mānuka honey (6 kg,  Haddrell’s, Cambridge, New Zealand) was 76 
used for the optimisation and testing of the extraction method.  Mānuka honey (15 kg, Natures 77 
Country Gold, Hamilton, New Zealand) was used for the isolation of flavonoids.  78 
 3 was used as a model compound and 4 as an analogue for the characterisation of 1.  3, 5-(2-79 
nitrophenyl)-2-furaldehyde, was obtained from Acros Organics.  4, 2-Formyl-5-phenyl-pyrrole, was 80 
generously donated by Dr J. T. Reeves of the Department of Chemical Development, Boehringer 81 
Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877-0368, USA. 82 
Methanol was redistilled from drum grade or HPLC grade (Scharlau), Milli-Q water was obtained 83 
from a Barnstead E-pure system (18.2 MΩcm).  Dried and purified diethyl ether, hexanes, 84 
tetrahydrofuran and dichloromethane were obtained from a Pure Solvent Purification System 85 
(Model: PS-SD-5) as needed and used promptly. Dimethyl sulfoxide-d6 (99.9 atom% D containing 86 
0.03% v/v TMS) and chloroform-d1 (99.8 atom% D) were obtained from Sigma-Aldrich Inc. Lithium 87 
diisopropylamide (LDA), o-methoxyacetophenone, oxazole-4-carboxaldehyde, diisobutylaluminium 88 
hydride (DIBALH) and triethylamine (Et3N) were obtained from Sigma-Aldrich Inc., methane 89 
sulphonyl chloride (MsCl) was obtained from Riedel-de Haën.  Caffeic acid (≥98%), (+)-catechin 90 
hydrate (98%), chlorogenic acid (predominantly trans) (≥ 95%), chrysin, trans-cinnamic acid (99+%),  91 
p-coumaric acid (≥ 98%), (-)-epicatechin (97%), galangin (no stated purity), gallic acid (97%), luteolin 92 
(≥ 98%), myricetin (approx 85%), pinocembrin (95%), quercetin dihydrate (98%), (+)-rutin hydrate 93 
(95%) and syringic acid (98%) were obtained from Sigma-Aldrich Inc., isorhamnetin (pure), 94 
kaempferol (pure) and naringin (pure) were obtained from Indofine Chemical Company Inc. 95 
5 
 
XAD-2 Amberlite resin (pore size 9 nm, particle size 0.3-1.2 mm) was obtained from Sigma-Aldrich 96 
Inc.  Sephadex LH-20 resin was obtained from Amersham Pharmacia Biotech AB and silica gel was 97 
obtained from Merck. 98 
General Methods:  Evaporation of aqueous samples under reduced pressure was accomplished 99 
using a rotary evaporator with a water bath set to 35 oC, smaller samples were reduced in volume 100 
by evaporation under a stream of dry nitrogen (35 oC). UV-Visible spectra of isolated flavonoids 101 
were recorded on a Varian Cary 100 Scan UV-Visible Spectrophotometer, sodium methoxide, 102 
sodium acetate, sodium acetate/boric acid, aluminium chloride and aluminium 103 
chloride/hydrochloric acid were variously added to measure changes in the UV spectrum 104 
(Markham & Mabry, 1975, Jurd, 1962, Mabry, Markham & Thomas,  1970) for purposes of 105 
identification.   106 
Isolation of Flavonoid Fraction: Phenolics were extracted from samples of honey using XAD-2 resin 107 
according to the method of Ferreres, Tomas-Barberan, Gil & Tomas-Lorente (1991).  Phenolic acids 108 
and flavonoids were separated using Sephadex-LH20 according to the method of Bohm (1998). 109 
Semi-preparative High Performance Liquid Chromatography (HPLC):  Semi-preparative HPLC of bulk 110 
fractions of honey for isolation of flavonoids was carried out using two Waters 515 pumps, an 111 
Alltech Elite Degassing System, a Rheodyne 7725i injector fitted with a 500 μL sample loop, and a 112 
Waters 996 photodiode array detector.  A reversed phase octadecylsilane Waters Xterra Prep 113 
column (PR18, 10 μm, 7.8 mm x 300 mm) was used in this system.  A binary mobile phase was used; 114 
this consisted of solvent A which was Milli-Q water acidified with acetic acid (0.075% v/v) and 115 
methanol (5% v/v) and solvent B which was methanol.  The overall flow rate was 4  mL/min.  The 116 
gradient used was held at 60% A for 5 min, decreasing to 50% A at 10 min and 20% A at 60 min and 117 
finally 0% A at 60.2 min.   118 
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Analysis of flavonoids and isolation of 1 by High Performance Liquid Chromatography (HPLC): 119 
Analysis of flavonoid extracts and isolation of 1 was carried out using two Waters 515 HPLC pumps 120 
with their flows combined through a static mixer (Grace Binary Large Volume Mixer SS Housing 121 
with 350 μL Mixer Cartridge). Both solvents were degassed prior to entering the pumps by passing 122 
through a Waters In-Line Degasser AF.  Samples and standards were warmed (40 oC) and injected 123 
manually using a Rheodyne 7725i injector system fitted with a Rheodyne loop (5 μL for analyses, 50 124 
μL for isolations).  Separation was achieved using a Waters Symmetry Shield™ octadecylsilane HPLC 125 
column (RP18, 5 μm, 3.0 x 250 mm) with a Waters Universal Sentry™ Guard SymmetryShield™ 126 
Column.  A binary gradient was used, solvent A was Milli-Q water and methanol (5% v/v), acidified 127 
with acetic acid (0.075% v/v), solvent B was methanol.  The gradient was run at a constant 128 
combined flow rate of 0.3 mL/min.  Detection was achieved using a Waters 996 Photodiode Array 129 
Detector (240-400 nm).  Gradient method 1 (for analyses and initial isolation of 1) consisted of 70% 130 
A for 15 min, decreasing to 40% A at 20 min and 0% A at 60 min and held for 10 min. Gradient 131 
method 2 (for final purification of 1) consisted of 70% A for 5 min, decreasing to 55% A at 10 min, 132 
20% A at 50 min and 0% A at 52 min and held for 8 min. 133 
Gas Chromatography-Mass-Spectrometry (GC-MS): GC-MS was carried out on a HP 6890 series GC 134 
fitted with a Phenomenex ZB-5 5% phenyl-methylsiloxane) column (30 m x 0.25 mm x 0.025 μm) 135 
interfaced to a HP 5973 mass selective detector.  Conditions used were 120 °C (0.75 min), 50 136 
°C/min up to 200 °C, and 10 °C/min up to 295 °C (held 15 min). The mass spectrometer was 137 
operated in either total ion chromatogram (TIC) or a selected ion monitoring (SIM) mode using  m/z 138 
201 (M+.), 158 and 130 ions in the case of 1. 139 
High Resolution Mass Spectrometry (HRMS): Mass spectra were recorded in positive-ion mode on a 140 
Bruker MicrOTOF mass spectrometer with electrospray interface and MeOH as mobile phase. 141 
Assignments of major peaks were confirmed by comparison of the high-resolution isotope pattern 142 
of the ions with the theoretical pattern obtained using isotope ratios. 143 
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Nuclear Magnetic Resonance Spectroscopy (NMR): 1D- and 2D- 1H and 13C NMR spectra of samples 144 
were obtained using a Bruker Avance DRX-400 spectrometer.  1H and 13C experiments were carried 145 
out at 400.13 and 100.62 MHz respectively using a 5 mm inverse 13C/1H probe head except for the 146 
13C spectrum of 1, which was acquired using a 5 mm dual 13C/1H probe head.  Samples were 147 
dissolved in dimethylsulfoxide-d6 or chloroform-d1 for NMR analysis.  Operation of the NMR 148 
spectrometer and processing of spectra were performed using Bruker Topspin 1.3 software.  149 
Measurement of UMF™: Measurement of non-peroxide antibacterial activity was carried out using 150 
the method previously described by Allen et al. (1991) and isolated fractions were mixed with 151 
clover honey as an artificial matrix for testing (Adams et al., 2008). 152 
Measurement of Bioactivity of 1:  Bioactivity testing was carried out at the ithree Institute, School 153 
of Medical and Molecular Sciences, University of Technology, Sydney, Australia.  Staphylococcus 154 
aureus strain NCTC 8325 was used throughout this part of the study. Growth assays were set up in 155 
cation-adjusted Mueller Hinton II Broth (CaMHB, Becton Dickinson) whereas biofilm assays were 156 
performed in tryptic soya broth (TSB, Oxoid). 157 
For a growth study, 1 was diluted in dimethyl sulfoxide (DMSO) and then further serial dilutions 158 
were made in DMSO. Each dilution was added in duplicate to a 96-well plate to a final DMSO 159 
concentration of 2%. An overnight culture was diluted to 1 x 108 cfu/mL (determined by back-160 
titration on tryptic soy agar plates) and 150 μL was added to each well of the 96-well plates. 161 
Controls included a serial dilution of Lincomycin (to assess plate-to-plate variation), a positive 162 
control with bacteria alone in CaMHB with 2% DMSO and a negative (no bacteria) with 150 μl 163 
CaMHB containing 2% DMSO. Plates were incubated in a shaking incubator at 37 oC for 22 h and 164 
absorbance was measured at a wavelength of 595 nm using a plate reader (Biotek Synergy HT). 165 
For a biofilm assay, plates were set up as for the growth assay except that bacteria were grown in 166 
TSB. Plates were then sealed with AeraSeal (Excel Scientific) and incubated at 37 oC in a humidified 167 
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incubator for 24 h. Plates were washed with PBS and dried at 60 oC for 1 h. Biofilm was stained by 168 
the addition of 200 µL of 0.2% crystal violet at room temperature for 1 h. Plates were washed 3 169 
times with water and air-dried and the amount of biofilm biomass was quantified by destaining the 170 
biofilm with 250 μL of 30% acetic acid.  Plates were incubated on a shaking platform at room 171 
temperature for 15 min and absorbance was then read at a wavelength of 635 nm. 172 
For a disc diffusion test, an overnight culture (100 μL) was streaked out with a sterile cotton swab 173 
on a tryptic agar plate.  Discs containing 10 μg of 1, rifampicin (positive control) or DMSO (negative 174 
control) were placed on the lawn of bacteria.  Plates were then incubated overnight at 37 oC and 175 
assessed for zones of bacterial inhibition. 176 
3-hydroxy-1-(2-methoxyphenyl)-3-(oxazol-4-yl) propan-1-one (5):  To THF (20 mL) at -84 oC was 177 
added LDA (2.5 mL, 5.5 mmol). The resultant solution of LDA was added dropwise to a solution of 178 
o-methoxyacetophenone (0.6 mL, 4.5 mmol). The reaction mixture was stirred at -84 oC for 30 179 
minutes before a solution of oxazole-4-carboxaldehyde (0.5 g, 5.5 mmol) in a minimal amount of 180 
THF was added dropwise at -84 oC.  The reaction mixture was stirred for 30 minutes at -84 oC, 181 
quenched with saturated aqueous NH4Cl (20 mL) and allowed to warm to room temperature.  The 182 
layers were allowed to separate, and the aqueous layer was extracted with EtOAc (2 x 20 mL).  The 183 
combined organic layers were dried (MgSO4), filtered and concentrated. The product was 184 
recrystallized from CH2Cl2/hexanes yielding 5 as pale yellow crystals (0.751 g, 68%), Mpt: 104 – 107 185 
oC, HRMS: found: 270.0735, calculated for C12H12NO4Na [M+Na]
+: 270.0737, 1H NMR (400.13 MHz, 186 
DMSO-d6) δ ppm 3.87 (s, 2-OCH3), 5.36 ( d, J = 5.4 Hz, OH), 3.26 (dd J = 8.2, 16.2 Hz, Ha-2’), 3.37 (dd 187 
J = 4.6, 16.2 Hz, Hb-2'), 5.06 (m, H-3'), 7.89 (s, H- 5'), 8.26 (s, H-6'), 7.16 (d, J = 8.6 Hz, H-3), 7.54 (t, J 188 
= 7.5 Hz, H-4), 7.03 (t, J = 7.5 Hz, H-5), 7.52 (d, J = 8.6 Hz ,H- 6), 13C NMR (100.62 MHz, DMSO-d6  189 
ppm 199.6 (C-1'), 50.4 (C-2'), 62.6 (C-3'), 143.3 (C-4'), 135.1 (C-5'), 151.5 (C-6'), 128.1 (C-1), 158.0 190 
(C-2), 112.3 (C-3), 133.6 (C-4), 120.9 (C-5), 129.4 (C-6). 191 
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2-formyl-5-(2-methoxyphenyl)-pyrrole (1): A solution of 5 (0.23 g, 0.9 mmol) in THF (4 mL) was 192 
treated at 0 oC with Et3N (0.4 mL) followed by dropwise addition of MsCl (0.1 mL), the reaction 193 
mixture was stirred at 0 oC for 1 h. Aqueous NaOH (2 M, 6 mL) was added and the reaction mixture 194 
heated (70 oC, 72 h). After cooling to room temperature, the reaction mixture was diluted with 195 
saturated aqueous NaHCO3 solution, extracted with EtOAc (2 x 20 mL) and the organic layer dried 196 
(MgSO4), filtered and concentrated. The product was purified by chromatography on a silica gel 197 
column (EtOAc – hexane, 1:9 → 1:0), the fraction containing 1 was concentrated and further 198 
purified with preparative layer chromatography using a circular plate (220 mm diameter, 2 mm 199 
silica layer: Merck PF245) installed on a Chromatotron (Harrison Research)  using 50 mL portions of 200 
hexane-diethyl ether mixtures (4:1, 2:3, 4:1) as eluent.  This yielded 1 as a yellow solid (0.36 mg, 201 
0.2%), HRMS: found: 224.0653, calculated for C12H11NO2Na [M+Na]
+: 224.0682,  1H NMR (400.13 202 
MHz) and 13C NMR (100.62 MHz) see Table 4. 203 
The major product formed during the synthesis of 1 was (E)-1-(2-methoxyphenyl)-3-(oxazol-4-yl)-204 
prop-2-en-1-one, 6, and its (Z)-isomer (minor) eluting in GC-MS at 6.28 min and 5.60 min 205 
respectively.  Chromatography under the conditions used for 1 gave 6 as orange crystals (0.075g, 206 
36%), Mpt: 75 – 80 oC, HRMS: found: 252.0644, calculated for C13H11NO3Na [M+Na]
+: 252.0631, 1H 207 
NMR (400.13 MHz, DMSO-d6)  ppm 3.86 (s, 2-OCH3), 7.42 (dd, J = 15.5, 0.8 Hz, H-2'), 7.35 (d, J = 208 
15.5 Hz, H-3'), 8.48 (t , J = 0.8 Hz, H-5'), 8.50 (s, H-6'), 7.19 (dd, J = 8.3, 1.0 Hz, H-3), 7.55 (td, J = 8.3, 209 
1.8 Hz, H-4), 7.06 (td, J = 7.5, 1.0 Hz, H-5), 7.48 (dd, J = 7.5, 1.8 Hz, H-6), 13C NMR (100.62 MHz), 210 
DMSO-d6  ppm 191.9 (C-1'), 131.1 (C-2'), 127.0 (C-3'), 136.3 (C-4'), 141.7 (C-5'), 153.1 (C-6'), 128.4 211 
(C-1), 157.7 (C-2), 112.3 (C-3), 133.1 (C-4), 120.6 (C-5), 129.5 (C-6), 55.8 (2-OCH3). The 
1H NMR 212 
spectrum of the crude reaction mixture also showed signals at 6.85 ppm (J = 12.6 Hz) and 6.99 ppm 213 
(J = 12.6 Hz) consistent with the presence of the olefinic protons of the corresponding (Z)-isomer.  214 
 215 
 216 
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RESULTS AND DISCUSSION 217 
Flavonoid profiles: The flavonoid profiles of 31 different mānuka honey samples were analysed. 218 
XAD-2 extraction was used according to the method of Ferreres et al. (1991) but modified to use 5 219 
g rather than 50 g samples, which modification was made to allow flavonoid profiling of a much 220 
larger set of honey samples.  To validate this modification multiple extractions of 50 g (3 221 
replicates), 20 g (3 replicates) and 5 g (5 replicates) samples were performed and the total area of 222 
the chromatogram (340 nm) in the phenolic region was measured. The results, (1.7 ± 0.8) x 108, 223 
(1.9 ± 1.0) x 108 and (2.1 ± 1.0) x 108 for 50, 20 and 5 g respectively, indicate that any variation due 224 
to sample size is insignificant compared with the intra-sample size variation.  Phenolic acids and 225 
flavonoids were separated using Sephadex-LH20 (Bohm, 1998).  The HPLC chromatogram of the 226 
flavonoid fraction of a typical mānuka honey is shown in Fig.1. Flavonoids and phenolic acids were 227 
identified by HPLC co-elution with an authentic standard and for some confirmed by isolation and 228 
characterisation by NMR and UV spectroscopy (caffeic acid, p-coumaric acid, pinobanksin and 8-229 
methoxykaempferol).  Several compounds were identified as flavonoids by their characteristic UV 230 
spectra, Table 1, but isolation and identification has so far proven elusive.   Unknown flavonoids  1, 231 
2 and 5 showed only a Band II absorption for max indicating that they are flavanones and/or 232 
dihydroflavonols while unknown flavonoids  3, 4 and 6 showed both Band I and Band II absorptions 233 
indicating that they are flavones and/or flavonols. Quantification of the flavonoids was achieved by 234 
comparing their absorbance in the HPLC chromatograms to four external standards.  Pinocembrin 235 
at 290 nm was used to quantify all flavanones and dihydroflavonols,  chrysin at 340 nm was used to 236 
quantify flavones and flavonols with unsubstituted B rings and kaempferol at 340 nm was used for 237 
those flavones and flavonols with a singly oxygenated B ring, while quercetin at 340 nm was used 238 
for all other flavones and flavonols, Table 2.  Total flavonoid content was 1.16 mg/100 g honey with 239 
a 95% confidence interval of 0.16 mg/100 g honey and a range of 0.594-2.235 mg/100 g honey. 240 
This value is considerably higher than the 0.0147 mg/100 g total flavonoid content reported by 241 
Weston et al. (2000) and closer to that reported by Yao et al. (2003), that is 3.06 mg/100 g of honey 242 
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for two samples.  Venugopal and Devarajan (2011) found 3.34 mg (chrysin equivalents)/100 g of 243 
honey in a single sample of mānuka honey using a chemical method.  244 
The principal flavonoids present in the HPLC chromatograms were pinobanksin  (PB, 0.27 ± 0.04 245 
mg/100 g honey), pinocembrin (PC, 0.17 ± 0.02 mg/100 g honey), luteolin (L, 0.14 ± 0.02 mg/100 g 246 
honey) and chrysin  (C, 0.13 ± 0.02 mg/100 g honey) and together these represented 61% of the 247 
total flavonoid content.  Hitherto Oelschlagel, Gruner, Wang, Boettcher, Koelling-Speer and  Speer 248 
(2012) have qualitatively reported the presence of luteolin in mānuka honey extracts analysed  by 249 
UPLC while Daher and Gülaçar (2010) have observed  the presence  of pinocembrin in two mānuka 250 
honey samples examined  by SPME followed by GC-MS.  251 
In this study in addition to the four principal flavonoids five other known flavonoids quercetin (Q) , 252 
8-methoxykaempferol (8MK), isorhamnetin (IR), kaempferol (K) and galangin (G) and six unknown 253 
flavonoids 1-6  (F1-6) were detected at lower levels.  In addition to the well known propolis-derived 254 
flavonoids pinocembrin, pinobanksin, chrysin and galangin,  as found for example in the studies of 255 
19 mānuka honeys by Weston, Mitchell and Allen(1999) and Weston et al. (2000), we detected the 256 
presence  of a  further five  known flavonoids  by comparison with standards.  The identification of 257 
chrysin and luteolin as major components of the flavonoid fraction of mānuka honey is consistent 258 
with the results of Yao et al. (2003) which showed quercetin (13.8%), isorhamnetin (12.9%), an 259 
unknown flavanone (12.7%), chrysin (12.6%) and luteolin (12.6%) as the main components of two 260 
mānuka honey samples;  isorhamnetin and quercetin were however only found at low levels in the 261 
present study. The quercetin content of the 31 mānuka honeys in the present study was found to 262 
be highly variable with levels ranging from 0.000 to 0.115 mg/100 g honey.  This high variability 263 
suggests that any quercetin found in mānuka honey probably originates from floral sources 264 
(introduced by nectar or pollen) other than mānuka trees.  Pinobanksin, which was the main 265 
component of the mānuka honey flavonoids in the present study, was not observed in the two 266 
mānuka honey samples analysed by Yao et al. (2003). In the current study a significant level (an 267 
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average of 14% of the total flavonoid content assuming a detector response similar to quercetin)of 268 
a non-flavonoid peak which eluted at 34.4 minutes,  1 (max 342 nm), was identified in all of the 269 
flavonoid extracts.   270 
Antibacterial activity of phenolic acid and flavonoid fractions: Fractions obtained from the XAD-2 271 
extraction were tested for antibacterial activity to determine the contribution of the phenolic acids 272 
and flavonoids to the non-peroxide, antibacterial activity of mānuka honey. The aqueous fraction 273 
of the XAD2 extraction contained the sugars and other polar compounds including methylglyoxal, 274 
and the methanol fraction contained the phenolics including the flavonoids and phenolic acids.  As 275 
a comparison, the activity of the original mānuka honey and a sample of inactive clover honey 276 
(used as an artificial matrix for the methanol fractions) were tested.  Extraction and testing was 277 
carried out in duplicate. The results of the activity testing are shown in Table 3.  The phenolic 278 
extract, at concentrations equivalent to natural honey, made such a small contribution to the non-279 
peroxide antibacterial activity it was not measurable by this assay, which concurred with the 280 
findings of Weston et al. (2000) and the attribution of this activity to water-soluble methylglyoxal 281 
(Adams et al., 2008, Mavric et al., 2008).  At 25 times their natural concentration the phenolics did 282 
display antibacterial activity, antibacterial activity has previously been attributed to such 283 
compounds as well as other types of bioactivity (Cushnie & Lamb, 2005, Havsteen, 2002, D’Arcy, 284 
2005). Although the flavonoid content of honey does not make a significant contribution directly to 285 
the non-peroxide antibacterial activity of honey, it is possible that there is some indirect 286 
contribution and to ascertain this, scatterplots were created of UMF™ versus peak area.  The only 287 
two substances from the flavonoid profile that showed activity correlations were the non-flavonoid 288 
compound  1 (R2 = 0.36) and luteolin (R2 = 0.23), Fig. 2.  289 
Isolation and characterisation of 1:  The observation that 1 showed a moderate R2 = 0.36 290 
correlation with UMF levels raised the possibility that it might be a minor contributor to the 291 
bioactivity of manuka honeys and also serve as a marker compound for UMF activity, it was 292 
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therefore of interest to isolate this substance and to determine its structure and ascertain if it 293 
exhibited any significant bioactivity.  1 was isolated from the flavonoid fraction by HPLC with 294 
gradient method 1 and purified by HPLC with gradient method 2, Fig. 3.  The 1H NMR spectrum of 1 295 
in DMSO-d6 gave a 3 proton singlet at 3.96 ppm typical of a -OCH3 or -COOCH3 group, 6 proton 296 
signals in the region 6-8 ppm typical of aromatic or conjugated olefinic protons and a singlet signal 297 
at 9.52 ppm suggestive of a -CHO group.  A broad peak at 11.79 ppm, which disappeared upon pre-298 
saturation of the HOD peak, was attributed to an exchangeable proton. H,H-COSY revealed the 299 
presence of two separate spin systems, a 2 proton spin system comprised of mutually coupled 300 
signals (J = 3.9 Hz) centred at 6.77 and 7.04 ppm.  The coupling constant exhibited by these 301 
protons, while not typical of a cis-coupled aryl proton or olefinic proton in a 7- or 8-membered ring, 302 
was typical of a cis-coupled proton in a 5-membered ring such as a furan, pyrrole or thiophene ring 303 
(27).  The second 4 proton system was comprised of signals centered at 7.02, 7.14, 7.33 and 7.77 304 
ppm and showed couplings and correlations typical of an ortho-substituted benzene.  The small 305 
quantity of isolated sample meant that 13C NMR showed only protonated signals even after 306 
prolonged acquisition, namely OCH3 (55.6 ppm), five or six aromatic or olefinic CH groups (114-307 
129.5 ppm) possibly including two unresolved signals at circa 120.7 ppm and a conjugated 308 
aldehyde group (178.8 ppm). This was verified in an HSQC spectrum. An HMBC spectrum 309 
determined with a 65 msec mixing time revealed the presence of 4 quaternary carbons at 156.2, 310 
136.5, 132.5 and 119.2 ppm.  A 1D selective NOESY experiment in which the aldehyde proton at 311 
9.52 ppm was irradiated enhanced the signal at 7.04 ppm indicating that the aldehyde group was 312 
spatially close to the cis-coupled proton spin system and distant from the aromatic protons.  A 313 
similar experiment irradiating the methoxyl protons caused enhancement of the aromatic proton 314 
at 7.77 ppm indicating that the methoxyl group was a substituent on the aromatic ring.  Thus it was 315 
concluded that 1 consisted of an ortho-substituted aromatic ring to which a methoxyl group was 316 
attached and a five-membered aromatic ring containing a heteroatom and to which an aldehyde 317 
group was attached. Hosoya et al. (2003) have reported the 1H NMR spectrum of 5-(2-318 
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methoxyphenyl)-2-furaldehyde (2 ) in chloroform-d1.  The reported spectrum of 2 shows similarities 319 
to that of 1, however the exchangeable proton at 11.79 ppm was not observed in 2.  320 
GCMS of 1 showed a base peak at m/z 201 and a much smaller peak at m/z 202.  Although aldehydes 321 
typically show a large [M-H]+, ion in this case it seemed likely that m/z  201 was the molecular ion and 322 
202 was the corresponding isotope peak. The molecular mass of 2 is 202 and the substitution of N for O 323 
in the five-membered ring would yield a molecular mass of 201 and be consistent with the presence of 324 
an exchangeable proton in 1.  325 
3 was utilised as a model compound to assist in identification of 1. The HMBC spectrum of 1 326 
determined with a correlation (mixing) time of 65 msec did not include correlations which defined the 327 
point at which the proposed pyrrole ring was linked to the methoxyl substituted ring.  A series of HMBC 328 
experiments were run using a specimen of 3 in which the mixing time was varied from 35 to 200 msec 329 
and the intensity of the correlation between H-6’ and C-5 was determined, this showed a maximum at 330 
50 msec. Using this optimised mixing time the HMBC spectrum of 1 revealed the presence of a 3J 331 
correlation between the aromatic proton at 7.77 ppm (H-6’) and a quaternary carbon (C-5) at 136.5 332 
ppm in the five-membered ring moiety.  Other structurally significant HMBC correlations observed for 1 333 
are depicted in Fig. 4. 334 
GC-MS analysis of 3, under identical conditions used for 1, afforded a peak which had a retention time 335 
of 11.98 min and showed a weak M+ ion at m/z 217 together with a base peak fragment ion at m/z 188 336 
attributable to a (M - CHO)+ ion.  The observation that the retention time of 3 was greater than that 337 
determined for 1 is consistent with the conclusion that 1 was a less polar, lower molecular weight 338 
variant of 3.  It was concluded that 1 was 2-formyl-5-(2-methoxyphenyl)-pyrrole.  Reeves, Song, Tan, 339 
Lee, Yee & Senanayake (2007) have reported the synthesis of another analogue of 1, 2-formyl-5-phenyl-340 
pyrrole, 4.  The structure of 4 only differs from that proposed for 1 in that it lacks the aryl ring methoxy 341 
substituent.  A sample of 4 was generously donated by Dr J.T. Reeves.  342 
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The 1H and 13C NMR assignments for 1 are given in Table 4 and compared with those which were 343 
determined for the specimen of 4 supplied by Dr Reeves.  Notable points of similarity in the 1H 344 
spectrum include the broad signal for the exchangeable proton attached to N, the chemical shift of the 345 
aldehyde proton and the coupling constant (3.9 Hz) of the cis-protons in the pyrrole ring.  When 1 was 346 
subsequently synthesised (see below) the 1H NMR spectrum was also recorded in chloroform-d1 and 347 
the two pyrrole protons (H-3' and H-4') which were doublets in DMSO-d6 were found to be a doublet of 348 
doublets in chloroform-d1.  Homonuclear decoupling irradiating the NH proton signal reduced H-3' and 349 
H-4' to doublets with J = 3.9 Hz. GC-MS analysis of 4, under identical conditions to those used for 1 and 350 
3 afforded a peak which had a retention time of 8.23 min and showed a M+ ion at m/z 171, together 351 
with strong m/z 170 [M-H]+, 142 [M - CHO]+ and  115 [M - C2H2ON]
+ fragment ions. 352 
Synthesis of 1:  The synthesis of 1 was undertaken following the method of Reeves et al. (2007), Scheme 353 
1.  The synthesis of 5 proceeded readily with 67.5% yield but the subsequent conversion to 1 gave 354 
predominantly the by-product (E)-1-(2-methoxyphenyl)-3-(oxazol-4-yl)-prop-2-en-1-one, 6, and a lesser 355 
amount of its (Z)-isomer, which are the outcome of the dehydration of 5, together with only a small 356 
amount of 1 . A significant quantity of o-methoxyacetophenone from the degradation of 5 was also 357 
present in the product mixture.  Based on the mechanism proposed by Reeves et al. (2007) 6 is an 358 
intermediate in the formation of 1 from 5.  It is probable that the subsequent nucleophilic attack by the 359 
N lone pair upon the carbonyl carbon is sterically hindered by the presence of the ortho methoxyl group 360 
and this prevents 1 from forming.  361 
Bioactivity of luteolin and 1: Notwithstanding the low yield (0.2%) of 1, the quantity of this compound 362 
that was isolated from the crude mixture by chromatography was sufficient for its bioactivity against 363 
S.aureus to be determined.  1 was found to be inactive at the concentrations screened (20 µg/mL-364 
0.1325 µg/mL).  On the other hand luteolin and its 4'-O-glucoside has been shown to have 365 
bactericidal activity against Staphylococcus aureus and Escherichia coli with MIC = 5.0 × 10-2-1.0 × 10-1 366 
mg/mL),  luteolin was also active against Bacillus cereus and Citrobacter freundii (MIC = 5.0 × 10-2 367 
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mg/mL) and  luteolin 3'-O-glucoside was active against Bacillus cereus and Lactobacillus plantarum with 368 
MIC = 2.5 × 10-1 mg/mL and 5 × 10-1 mg/mL respectively (Kumarasamy, Nahar, Byres, Delazar & Sarker, 369 
2005).  However the mean concentration at which luteolin is present in mānuka honey (0.14 ± 0.02 370 
mg/100 g honey) shows that it would be unlikely to attain any of these minimum inhibitory 371 
concentrations in a well-diffusion assay as used in this study. 372 
CONCLUSIONS 373 
Analysis of the flavonoid profiles of a large sample set of mānuka honeys gave a mean total flavonoid 374 
content of 1.16 mg/100g of honey with pinobanksin, pinocembrin, luteolin and chrysin as the principal 375 
flavonoids present. Although the phenolic acids and flavonoids did not contribute directly to the non-376 
peroxide antibacterial activity of the honey, luteolin and non-flavonoid compound 1 were weakly 377 
correlated with measured activity. 1 and the principal flavonoid which does not derive from propolis, 378 
luteolin, are potential marker compounds for mānuka monofloral honey and their correlation with non-379 
peroxide antibacterial activity could be explained if one assumes that the activity of the honey is 380 
directly related to the proportion of mānuka in the blend.  381 
1 was isolated and characterised by NMR and MS methods and its structure was confirmed by 382 
synthesis. 1 showed no bioactivity against S. aureus. The lack of bioactivity indicates that the moderate 383 
correlation (R2 = 0.36) which 1 exhibited with non-peroxide antibacterial activity does not arise by a 384 
direct contribution from 1.   At the concentration in which it is present in mānuka honey, luteolin is also 385 
unlikely to make a direct contribution to non-peroxide antibacterial activity. Given that the total 386 
phenolic fraction was inactive at the concentrations normally present in mānuka honey, there is no 387 
indication of synergy between 1 and other phenolics including luteolin.   388 
 389 
390 
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Captions for Tables and Figures 
Fig. 1: HPLC chromatogram (gradient method 1) of flavonoid fraction of mānuka honey at  290 and 
340 nm: (1) caffeic acid, (2) isoferulic acid, (3) p-coumaric acid, (4) pinobanksin, (5) unknown 
compound 1, (6) unknown flavonoid 01, (7) luteolin, (8) unknown flavonoid 02, (9) pinocembrin, 
(10) unknown flavonoid 03,  (11) unknown flavonoid 04, (12) unknown flavonoid 05, (13) chrysin, 
and (14) galangin. 
Fig. 2: Scatterplot of (a) unknown compound 1 and (b) luteolin concentration versus UMF™ non-
peroxide antibacterial activity. 
Fig. 3: HPLC chromatogram (gradient method 2, 340 nm) of purified 1. 
Fig. 4: HMBC correlations observed in 1. 
Scheme 1: Synthesis of 1 
Table 1: Retention times of phenolic acids and flavonoids found in the flavonoid fraction of mānuka 
honeys : pinobanksin (3,5,7-trihydroxyflavanone), unknown compound 1, unknown flavonoid 1, 
quercetin (3,5,7,3,4-pentahydroxyflavone), luteolin (5,7,3,4-tetrahydroxyflavone), unknown 
flavonoid 2, 8-methoxykaempferol (3,5,7,4-tetrahydroxy-8-methoxyflavone), pinocembrin (5,7-
dihydroxyflavone), unknown flavonoid 3, isorhamnetin (3,5,7,4-tetrahydroxy-3-methoxyflavone), 
unknown flavonoid 4, kaempferol (3,5,7,4-tetrahydroxyflavone), unknown flavonoid 5, chrysin 
(5,7-dihydroxyflavone), galangin (3,5,7-trihydroxyflavone), unknown flavonoid 6. 
Table 2: Quantitation of flavonoids in mānuka honeys (UMF = non-peroxide antibacterial activity, 
mean of 12 determinations, other abbreviations as for Table 1) 
Table 3: Non-peroxide antibacterial activity of fractions from XAD-2 separation of mānuka honey 
Table 4: NMR signals assignments for 1 and 4 (δ ppm in DMSO-d6) 
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Table 1 
Name Identificationa Quantificationb Rt (min)
c λmax (nm)
d 
Caffeic acid I e 23.3 325 
Isoferulic acid I e 35.7 324 
p-Coumaric acid I e 26.5 310 
Pinobanksin (PB) I P 33.9 292 
1 I Q 34.4 342 
Unknown flavonoid 1(F1) NA P 38.3 286 
Quercetin (Q) S Q 38.7 367, 256 
Luteolin (L) S Q 39.3 350, 255 
Unknown flavonoid 2 (F2) NA P 40.4 292 
8-Methoxykaempferol (8MK) I K 41.2 375, 272 
Pinocembrin (PC) S P 41.5 290 
Unknown flavonoid 3 (F3) NA Q 42.4 360, 258 
Unknown flavonoid 4 (F4) NA K 43.7 361, 253 
Isorhamnetin (IR) S K 44.3 373, 255 
Kaempferol (K) S K 45.5 364, 255 
Unknown flavonoid 5 (F5) NA P 46.4 291 
Chrysin (C) S C 46.7 314, 269 
Galangin (G) S C 50.0 360, 266 
Unknown flavonoid 6 (F6) NA C 50.6 311, 269 
a Method used to identify the compound: S = authentic standard, I = isolation and characterisation 
and NA = not identified. 
b Quantification standard used: Q = quercetin, K = kaempferol, P = pinocembrin and C = chrysin. 
c HPLC retention time. 
d  Peak maxima in the UV absorbance spectrum (240 – 400 nm). 
e Phenolic Acids were not quantified as their presence in this fraction represents only a portion of 
their total presence in the honey. 
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Concentration of flavonoids (mg/100g of honey) 
Sample UMF PB 1 F1 Q L F2 8MK PC F3 F4 IRM K F5 C G F6 Total 
1 7.7 0.343 0.109 0.058 0.000 0.114 0.037 0.013 0.200 0.013 0.016 0.020 0.017 0.006 0.102 0.027 0.009 1.083 
2 11.1 0.313 0.152 0.065 0.020 0.130 0.036 0.017 0.213 0.013 0.029 0.026 0.019 0.009 0.118 0.052 0.016 1.229 
3 15.8 0.365 0.126 0.071 0.031 0.163 0.040 0.025 0.206 0.023 0.046 0.030 0.038 0.014 0.207 0.083 0.014 1.482 
4 17.1 0.392 0.240 0.062 0.115 0.138 0.042 0.004 0.231 0.018 0.092 0.034 0.146 0.012 0.442 0.051 0.016 2.036 
5 22.9 0.224 0.205 0.043 0.040 0.169 0.028 0.008 0.128 0.023 0.036 0.030 0.072 0.005 0.246 0.020 0.007 1.285 
6 27 0.200 0.279 0.039 0.016 0.147 0.015 0.010 0.112 0.013 0.016 0.016 0.012 0.006 0.081 0.021 0.008 0.990 
7 13.8 0.585 0.420 0.094 0.037 0.268 0.040 0.036 0.337 0.030 0.044 0.042 0.027 0.016 0.168 0.072 0.020 2.235 
8 17.7 0.297 0.188 0.039 0.049 0.121 0.023 0.020 0.157 0.018 0.024 0.024 0.072 0.004 0.151 0.033 0.011 1.231 
9 20 0.166 0.229 0.047 0.006 0.202 0.027 0.010 0.129 0.015 0.020 0.017 0.013 0.008 0.081 0.038 0.013 1.021 
10 27.3 0.144 0.254 0.058 0.002 0.111 0.022 0.014 0.137 0.010 0.016 0.016 0.006 0.012 0.086 0.023 0.011 0.923 
11 25.3 0.062 0.130 0.027 0.013 0.110 0.015 0.005 0.070 0.007 0.018 0.009 0.007 0.004 0.075 0.034 0.008 0.594 
12 23.6 0.262 0.232 0.075 0.014 0.334 0.062 0.019 0.227 0.020 0.040 0.025 0.022 0.020 0.168 0.078 0.024 1.622 
13 17.5 0.279 0.183 0.068 0.020 0.160 0.033 0.009 0.146 0.023 0.032 0.028 0.021 0.006 0.103 0.043 0.008 1.162 
14 17.7 0.240 0.138 0.082 0.043 0.170 0.043 0.016 0.127 0.020 0.042 0.017 0.016 0.003 0.070 0.030 0.005 1.062 
15 13.9 0.310 0.274 0.066 0.051 0.172 0.045 0.016 0.197 0.018 0.037 0.031 0.019 0.010 0.104 0.053 0.013 1.417 
16 14.8 0.254 0.291 0.064 0.000 0.133 0.047 0.011 0.191 0.015 0.029 0.023 0.016 0.009 0.090 0.042 0.010 1.225 
17 14.9 0.197 0.123 0.048 0.010 0.174 0.058 0.000 0.142 0.007 0.025 0.015 0.012 0.009 0.082 0.047 0.011 0.960 
18 10.9 0.141 0.088 0.060 0.012 0.051 0.026 0.005 0.110 0.006 0.017 0.009 0.006 0.003 0.043 0.016 0.006 0.599 
19 15.3 0.125 0.158 0.067 0.035 0.211 0.035 0.015 0.102 0.012 0.022 0.013 0.016 0.003 0.052 0.021 0.005 0.894 
20 14.2 0.273 0.105 0.112 0.000 0.082 0.063 0.000 0.176 0.000 0.012 0.013 0.000 0.003 0.038 0.017 0.005 0.899 
21 14.2 0.336 0.092 0.129 0.000 0.092 0.098 0.009 0.312 0.017 0.017 0.025 0.000 0.010 0.099 0.054 0.011 1.302 
22 1 0.340 0.039 0.034 0.017 0.029 0.018 0.083 0.239 0.010 0.017 0.017 0.011 0.003 0.051 0.016 0.004 0.927 
23 9.2 0.291 0.073 0.081 0.000 0.047 0.029 0.004 0.186 0.000 0.010 0.014 0.000 0.006 0.047 0.017 0.008 0.813 
24 8.3 0.235 0.075 0.075 0.000 0.051 0.017 0.000 0.164 0.000 0.008 0.014 0.000 0.007 0.046 0.015 0.005 0.711 
25 9.3 0.211 0.087 0.052 0.000 0.064 0.010 0.002 0.129 0.006 0.008 0.011 0.002 0.003 0.032 0.011 0.004 0.631 
26 7.3 0.325 0.004 0.056 0.017 0.128 0.023 0.007 0.185 0.014 0.018 0.017 0.016 0.004 0.064 0.022 0.004 0.904 
27 7.3 0.276 0.063 0.054 0.000 0.171 0.050 0.011 0.248 0.011 0.026 0.024 0.021 0.016 0.133 0.054 0.018 1.178 
28 8 0.284 0.081 0.059 0.000 0.048 0.026 0.007 0.177 0.005 0.012 0.015 0.031 0.005 0.060 0.022 0.005 0.837 
29 5.9 0.269 0.059 0.057 0.000 0.098 0.057 0.008 0.181 0.007 0.009 0.015 0.004 0.007 0.048 0.018 0.003 0.841 
30 4.5 0.309 0.051 0.044 0.000 0.131 0.061 0.003 0.018 0.004 0.012 0.021 0.008 0.005 0.063 0.020 0.004 0.754 
31 0 0.264 0.064 0.049 0.000 0.144 0.045 0.005 0.198 0.007 0.016 0.019 0.021 0.004 0.061 0.024 0.005 0.926 
Mean   0.273 0.157 0.061 0.024 0.136 0.038 0.012 0.174 0.013 0.029 0.022 0.032 0.008 0.131 0.035 0.010 1.155 
S.D. 
 
0.095 0.096 0.021 0.043 0.062 0.018 0.014 0.064 0.008 0.029 0.009 0.051 0.005 0.132 0.020 0.005 0.461 
95% C.I. 
 
0.034 0.034 0.008 0.015 0.022 0.006 0.005 0.023 0.003 0.010 0.003 0.018 0.002 0.047 0.007 0.002 0.164 
CV (%) 
 
34.9 61.3 34.7 175.8 45.7 47.4 120.7 36.6 60.8 99.5 43.3 161.5 60.3 100.4 56.4 56.8 39.9 
%
 
of total    23.6 13.6 5.3 2.1 11.8 3.3 1.0 15.1 1.2 2.5 1.9 2.7 0.7 11.4 3.0 0.8   
Table 2 
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Table 3 
Fraction from XAD-2 Non-Peroxide Antibacterial Activity 
(% Phenol Equivalents) 
Aqueous sugar fraction 30.5 ± 0.7a 
MeOH phenolic fraction 1:1 No detectable activity a 
MeOH phenolic fraction 25:1 37 ± 1 b 
Manuka honey 30.6 ± 0.8 a 
Clover honey No detectable activity b 
aMean and 95% confidence interval from 48 determinations. 
bMean and 95% confidence interval from 32 determinations. 
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Table 4 
 1  4a  
 13C 1H 13C 1H 
1-NH  11.79 (br s) 12.39 (br s) 
2 132.5  133.8 
3 120.5 7.04b (d, J = 3.9 Hz) 121.9 7.08 (dd, J = 3.9, 2.3 Hz) 
4 111.4 6.77 (d, J = 3.9 Hz) 108.9 6.79 (dd, J = 3.9, 2.3 Hz) 
5 136.5  139.5 
2-CHO 178.8 9.52 s 178.8  9.50 s 
1' 119.2  130.9 
2' 156.2  125.5 7.89 (d, J = 8.0 Hz) 
3' 112.1 7.14 (dd, J = 8.5, 1.2 Hz) 128.7 7.42 (t, J = 8.0 Hz) 
4' 129.4 7.33 (ddd, J = 8.5, 7.3, 1.7 Hz) 127.9 7.32 (t, J = 8.0 Hz) 
5' 120.7 7.02b (~td, J = 8.3, 1.2 Hz) 128.7 7.42 (t, J = 8.0 Hz) 
6' 128.4 7.77 (dd, J = 7.8, 1.7 Hz) 125.5 7.89 (d, J = 8.0 Hz) 
2'-OCH3 55.6 3.96 s 
asample kindly supplied by Dr Reeves;  bsignals partly overlapped 
 
